Sale!

MECP2 Gene Mental Retardation X-Linked Type 13 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MECP2 Gene Mental Retardation X-Linked Type 13 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the MECP2 gene, which are closely associated with X-linked mental retardation type 13. This condition is part of a spectrum of neurological disorders that can affect cognitive function, development, speech, and motor skills, often manifesting early in life. The MECP2 gene plays a crucial role in the development of the nervous system and its proper functioning. Mutations in this gene can lead to various degrees of intellectual disability and physical challenges.

Given the complexity of the genetic analysis, the test is priced at 4400 AED. It involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the state-of-the-art facilities of DNA Labs UAE. The laboratory employs cutting-edge genetic sequencing technologies to detect any abnormalities in the MECP2 gene that might indicate the presence of X-linked mental retardation type 13.

This test is particularly recommended for families with a history of the condition or when children present with symptoms that could suggest a genetic disorder affecting cognitive and physical development. Early diagnosis through the MECP2 Gene Mental Retardation X-Linked Type 13 Genetic Test can be crucial in managing the condition, allowing for tailored interventions and support to improve the quality of life for those affected.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MECP2 Gene Mental Retardation X-Linked Type 13 Genetic Test

Are you concerned about mental retardation or Rett syndrome? The MECP2 Gene Mental Retardation X-Linked Type 13 Genetic Test offered by DNA Labs UAE can provide you with the answers you need. This blog post will provide you with detailed information about the test, including its components, price, sample condition, report delivery, method, test type, doctor, test department, pre-test information, and test details.

Test Components

The MECP2 Gene Mental Retardation X-Linked Type 13 Genetic Test includes the following components:

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre-Test Information

Prior to undergoing the MECP2 Gene Mental Retardation X-Linked Type 13 Genetic Test, it is important to provide the following information:

  • Clinical History of the Patient who is going for MECP2 Gene Mental Retardation, X-Linked Type 13 NGS Genetic DNA Test
  • A Genetic Counselling session to draw a pedigree chart of family members affected with MECP2 Gene Mental Retardation, X-Linked Type 13

Test Details

The MECP2 gene is located on the X chromosome and is responsible for producing a protein called methyl-CpG-binding protein 2 (MeCP2). Mutations in the MECP2 gene can lead to various disorders, including Rett syndrome, which is characterized by severe intellectual disability and other neurological symptoms.

NGS (Next-Generation Sequencing) genetic testing is a high-throughput method used to analyze multiple genes simultaneously. In the case of MECP2 gene testing, NGS can identify mutations or variants within the gene that may be associated with mental retardation or Rett syndrome.

Mental retardation, X-Linked Type 13 refers to a specific subtype of X-linked intellectual disability caused by mutations in the MECP2 gene. NGS genetic testing for the MECP2 gene can help diagnose individuals with suspected Rett syndrome or other related disorders. It involves analyzing the DNA sequence of the gene to identify any changes or mutations that may be present.

This type of genetic testing can be useful for individuals with symptoms of intellectual disability, developmental delays, or other neurological issues, as it can provide a definitive diagnosis and help guide appropriate medical management and treatment options. It can also be used for carrier testing or prenatal testing in families with a known MECP2 gene mutation.

It’s important to consult with a healthcare professional or genetic counselor to discuss the specific indications, benefits, and limitations of MECP2 gene NGS testing in individual cases.

Test Name MECP2 Gene Mental retardation X-Linked type 13 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MECP2 Gene Mental retardation, X-Linked type 13 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MECP2 Gene Mental retardation, X-Linked type 13
Test Details

The MECP2 gene is located on the X chromosome and provides instructions for making a protein called methyl-CpG-binding protein 2 (MeCP2). Mutations in the MECP2 gene can lead to various disorders, including a condition called Rett syndrome, which is characterized by severe intellectual disability and other neurological symptoms.

NGS (Next-Generation Sequencing) genetic testing is a high-throughput method used to analyze multiple genes simultaneously. In the case of MECP2 gene testing, NGS can identify mutations or variants within the gene that may be associated with mental retardation or Rett syndrome.

Mental retardation, X-Linked type 13 refers to a specific subtype of X-linked intellectual disability caused by mutations in the MECP2 gene.

NGS genetic testing for the MECP2 gene can help diagnose individuals with suspected Rett syndrome or other related disorders. It involves analyzing the DNA sequence of the gene to identify any changes or mutations that may be present.

This type of genetic testing can be useful for individuals with symptoms of intellectual disability, developmental delays, or other neurological issues, as it can provide a definitive diagnosis and help guide appropriate medical management and treatment options. It can also be used for carrier testing or prenatal testing in families with a known MECP2 gene mutation.

It’s important to consult with a healthcare professional or genetic counselor to discuss the specific indications, benefits, and limitations of MECP2 gene NGS testing in individual cases.